In July 2011, Lundbeck published the results of a double-blind, randomized, placebo-controlled clinical trial with venlafaxine as an active reference, it was found to be superior to placebo in treating MDD while having fewer side effects than Venlafaxine.
Lundbeck published the results of a double-blind, randomized, placebo-controlled clinical trial with venlafaxine as an active reference, it was found to be superior to placebo in treating MDD while having fewer side effects than Venlafaxine. This was in July 2011.